Pharma.Aero onboards DSV as full member and Mytigate as associate partner

Pharma.Aero welcomes the global transport and logistics provider DSV as full member and the pharma supply chain risk management platform Mytigate as associate partner.
The international cross-industry collaboration platform now comprises of 46 members and associate partners from LifeScience and MedTech shippers, IATA CEIV certified cargo communities, airport operators and other air cargo industry stakeholders.

Frank Van Gelder, Secretary General of Pharma.Aero:
“Pharma.Aero is happy to welcome DSV to its global membership network. Increasing our membership with strong global players with a dedicated life science focus will benefit to the air transportation and handling of pharmaceutical and vaccine shipments. Global collaboration and sharing of expertise are pivotal within the air cargo industry to further increase the reliable transport.
In addition to DSV, we welcome Mytigate as one of our associate partners. This will further spread the technology insights and solutions supporting traceability, visibility, and transparency of the end-to-end pharma supply chain. 
Both companies showed immediate dedication and input to the second International Masterclass  on Pharma Logistics in Abu Dhabi from the 5^th to 9^th of September, being part of the program and sponsorship."  
 
Eric ten Kate, Vice President, Global Vertical Lead Healthcare, DSV:
“We are excited to be joining Pharma.Aero as a Full Member. The platform allows us to collaborate with the different stakeholders in the pharma supply chain and contribute to the overall mission to improve the quality of pharma transportation.
it is a privilege to be part of a global community working toward raising the standards and defining solutions across multiple pharma-related fields and business markets. This aligns with DSV’s global healthcare strategy to ultimately assure patient safety at all times.”
 
Yvonne Ziegler, CEO Mytigate GmbH:
“Mytigate feels honoured to join Pharma.Aero as an Associate Partner and looks forward to contributing to its mission to improve the quality of pharma transportation.”
 
About DSV – Global Transport and Logistics
DSV provides and manages supply chain solutions for thousands of companies every day – from small family–run businesses to large global corporations. 
Our reach is global, yet our presence is local and close to our customers. 75,000 employees in more than 90 countries work passionately to deliver great customer experiences and high-quality services.
Read more at www.dsv.com 
 
About Mytigate
Mytigate, a firm established in Eschborn, Germany, began its operations in 2020.  It is a digital platform that helps pharmaceutical companies and their forwarders to conduct pharma lane risk assessments in order to ensure compliance with good distribution practice (GDP) regulations and to improve the quality of pharma transport. 
Mytigate operationalizes the results of the "Pharma Supply Chain Risk Management" research project, which was initiated by Frankfurt University together with Bayer AG, Boehringer Ingelheim Pharma GmbH & Co. KG and the forwarder GEFCO Forwarding Germany GmbH. The project was funded by the LOEWE3 innovation fund of the state of Hesse that supports outstanding joint scientific projects between universities and private firms.
The company's primary goal is to assess pharma lane risks, through ensuring compliance with good distribution practice (GDP) rules, to reduce the impact of pharma transport incidents. It is a digital platform that helps pharmaceutical businesses, forwarders, and supply-chain partners comply with regulations.
 
About Pharma.Aero
Pharma.Aero is a leading international cross-industry collaboration platform for LifeScience and MedTech shippers, IATA CEIV certified cargo communities, airport operators and other air cargo industry stakeholders. Jointly with our members, we ideate and develop projects that focus on end-to-end supply chain visibility and address air transportation issues and challenges faced by the Life Science and MedTech industry.
Since its foundation, in 2016, Pharma.Aero expanded rapidly its network to 46 members, associates, and partners, and it is now present on 6 continents. Over the years, Pharma.Aero completed 9 projects, thus giving its members access to valuable insights, ideas, and solutions.
In 2022, Pharma.Aero is breaking new grounds by simultaneously conducting 4 projects that address innovative and futuristic challenges of transporting Life Science and Medtech products.
 
For more information on our projects and membership, contact us at frank.vangelder@pharma.aero or projects@pharma.aero.